Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3737-3742

  Scala, Stefania ^a   Wosikowski, Katja ^a   Giannakakou, Paraskevi ^a   Valle, Paola ^a   Biedler, June L ^b   Spengler, Barbara A ^b   Lucarelli, Enrico ^a   Bates, Susan E ^a   Thiele, Carol J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; DACTINOMYCIN; GLYCOPROTEIN P; PACLITAXEL; PROTEIN TYROSINE KINASE; RETINOIC ACID; TUBULIN; VINBLASTINE;

ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; NEUROBLASTOMA CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG RESISTANCE; HUMANS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; P-GLYCOPROTEIN; RNA, MESSENGER; TRETINOIN; TUBULIN; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0029778770     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Brodeur, G , Pritchard, J , Berthold, F , Carlsen, N., and Castel, V. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol., 11: 1466-1477, 1993
2. Nakagawara, A , Arima-Nakagawara, M , Scavarda, N , Azar, C., Cantor, A , and Brodeur, G Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med., 328: 847-854, 1993.
3. Levi-Montalcini, R. The nerve growth factor: thirty-five years later. Science (Washington DC), 237: 1154-1164, 1987.
4. Heumann, R. Neurotrophins signaling Curr Opin. Neurobiol., 6: 668-679, 1994.
5. Persson, H., and Ibanez, C Role and expression of neurotrophins and the trk family of tyrosine kinase receptors in neuronal growth and rescue after injury Curr. Opin Neurol. Neurosurg., 6: 11-18, 1993
6. Matsumoto, K., Wada, R., Yamashiro, J., Kaplan, D., and Thiele, C. Expression of brain derived neurotrophic factor and p145TrkB affects survival, differentiation and invasiveness in human neuroblastoma cell lines Cancer Res., 55: 1798-1806, 1995.
7. Nakagawara, A. Azar, C , Scavarda, N , and Brodeur, G. Expression and function of TRK-B and BDNF in human neuroblastoma. Mol. Cell Biol , 14: 759-767, 1994.
8. Ventimiglia, R., Mather, P , Jones, B., and Lindsay, R. The neurotrophins BDNF, NT-3 and NT 4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J. Neurosci , 7 213-222, 1995.
9. Acheson, A , Conover, J., Fandl, J., DeChiara, T., Russel, M., Thadani, A., Squinto, S., Yancopoulos, G., and Lindsay, R A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature (Lond.), 374: 405-406, 1995
10. Cheng, B , and Mattson, M. NT-3 and BDNF protects CNS neurons against metabolic/excitoxic insults Brain Res., 640: 56-67, 1994.
11. Lindholm, D , Dechant, G., Heinsenberg, C., and Thoenen, H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci., 5: 1455-1464, 1993.
12. Johnson, E. Destruction of the sympathetic nervous system in neonatal rats and hamsters by vinblastine prevention by concomitant administration of nerve growth factor. Brain Res., 141: 105-118, 1978.
13. Shimohama, S., Tamura, Y., Akaike, A , Tsukahara, T., Ohara, O., Watanabe, S , and Kimura, J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neuroscience, 164: 55-58, 1993.
14. Wozniak, W. Brain-derived neurotrophic factor (BDNF), role in neuronal development and survival Folia Morphol. (Prague), 52: 173-181, 1993.
15. La Quaglia, M , Kopp, E., Spengler, B., Meyers, M., and Biedler, J Multidrug resistance in human neuroblastoma cells. J. Pediatr. Surg , 26: 1107-1112, 1991.
16. Spengler, B., Ross, R., and Biedler, J. Differential drug sensitivity of human neuroblastoma cells. Cancer Treat Rep., 70: 959-965, 1986
17. Chan, H., Haddad, G , and Thorner, P. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J Med., 325: 1608-1614, 1991.
18. Ferrandis, E., Da Silva, J., Riou, G , and Benard, L. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res., 54: 2256-2261, 1994.
19. Nakagawara, A , Kadomatsu, K., Sato, S., Kohno, K., Takano, H., Akazawa, K., Nose, Y , and Kuwano. M Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastoma. Cancer Res., 50: 3043-3047, 1990.
20. Norris, M. D , Bordow, S. B., Marshall, G. M., Haber, P S , Cohn, S L , and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J Med., 334: 231-238, 1996.
21. Kaplan, D , Matsumoto, K , Lucarelli, E., and Thiele, C. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron, 11: 321-331, 1993
22. Biedler, J., Casals, D , Chang, T., Meyers, M , Spengler, B., and Ross, A Multidrug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation. Prog. Clin. Bio. Res., 3: 181-191, 1991.
23. Fojo, A., Akiyama, S., Gottesman, M., and Pastan, I Reduced drug accumulation in multidrug resistant human KB carcinoma cell lines. Cancer Res., 45: 3002-3007, 1985.
24. Skehan, P., Storeg, R., Scudiero, D , Monks, A., McMahon, J., Vistica, D., Warren, J., Bokesh, H., Kenney, S., and Boyd, M. New colorimetric cytotoxicity assay for anticancer drug screening J Natl. Cancer Inst , 82: 1107-1112, 1990.
25. Thiele, C., Cohen, P., and Israel, M. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid induced differentiation. Mol. Cell. Biol., 8: 1677-1683, 1988.
26. Mickley, L., Bates, S., Chen, Y., Richert, N., Rudick, N., Biedler, J., and Fojo, A Modulation of the expression of a multidrug resistance gene (mdr-I/P-glycoprotein) by differentiating agents. J. Biol. Chem., 264 18031-18040, 1989.
27. Jones, R., and Reichardt, L. Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc. Natl Acad. Sci USA, 87: 8060-8064, 1990.
28. Minotti, A , Barilow, B., and Cabral, F. Resistance to antimitotic drug in CHO cells correlates with changes in the level of polymerized tubulin. J. Biol. Chem , 266: 3987-3994, 1991.
29. Bates, S., Mickley, L , Chen, Y , Richert, N., Rudick, J., Biedler, J , and Fojo, A. Expression of a drug resistance gene in human neuroblastoma cell line: modulation by retinoic acid-induced differentiation Mol. Cell. Biol., 9: 4337-4344, 1989.
30. Lee, J , Paull, K., Alvarez, M., Hose, C., Monks, A., Grever, M., Fojo, A., and Bates, S Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol., 46: 627-638, 1994.
31. Campenot, R. NGF and the local control of the terminal growth. J Neurobiol, 25: 599-611, 1994.
32. Di Stefano, P., Friedman, B , Radziejewski, C., Alexander, C., Boland, P., Schick, C., Lindsay, R , and Wiegand, S. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons Neuron, 8: 983-993, 1992.
33. Okazawa, H , Nishiyama, K , Kamei, M., Wishizaki, K., Murayama, S , Kwak, S., and Kanazawa, I. Trk immunoreactivity at neuronal dendrite and cell body. Biochem. Biophys. Res. Commun , 194: 683-690, 1993.
34. von Bartheld, C , Kinoshita, Y., Prevette, D., Yin, Q. W., Oppenhaim, R. W., and Bothwell, M Positive and negative effects of neurotrophins on the isthino-optic nucleus in chick embryos. Neuron, 12: 639-654, 1994.
35. Ilag, L , Curtis, R., Glass, D., Funakoshi, H., Tobkes, N. J., Ryan, T. E., Acheson, A , Lindsay, R M., Persson, H., and Yancopoulos, G. D. Pan-neurotrophin 1, a genetically engineered neurotrophic factor displaying multiple specificities in peripheral neurons in vitro and in vivo Proc. Natl. Acad. Sci. USA, 92: 607-611, 1995.
36. Yan, Q., Elliot, J., Matheson, C , Sun, J., Zhang, L., Mu, X., Rex, R., and Snider, W. Influences of neurotrophins on mammalian motor neurons in vivo. J Neurobiol , 24 1555-1577, 1993.
37. Ehrhard, P., Ganter, U., Schmutz, B., Bauer, J., and Otten, U. Expression of low-affinity NGF receptor and trkB mRNA in human SY5Y neuroblastoma cells. FEBS Lett., 330: 287-292, 1993
38. Baker, D , Reddy, U., Pleasure, D., Thorpe, C., Evans, A , Cohen, P., and Ross, A Analysis of nerve growth factor receptor expression in human neuroblastoma and neuroepithelioma cell lines. Cancer Res., 49: 4142-4126, 1989
39. Dobrowsky, R. T , Jenkins, G. M., and Hannun, Y. A. Neurotrophins induce sphingomyelin hydrolysis Modulation by co-expression of p75NTR with Trk receptors J Biol Chem., 270: 22135-22142, 1995
40. Dobrowsky, R. T., Werner, M. H., Castellino, A. M., Chao, M. V., and Hannun, Y. A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor Science Washington DC), 265: 1596-1599, 1994
41. Squinto, S. P., Stitt, T. N., Aldrich, T H., Davis, S , Bianco, S. M , Radziejewski, C., Glass, D J , Masiakowski, P., Furth, M. E., Valenzuela, D. M., De Stefano, P. S., and Yancopoulos, G, D trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell, 65: 885-894, 1991
42. Roback, J., Marsh, N., Downen, M., Palfrey, C., and Wainer, B BDNF-activated signal transduction in rat cortical glial cells. Eur. J. Neurosci , 7: 849-862, 1995
43. Haber, M., Buritt, C., Regl, D , Madafiglio, J , Norris, M , and Horowitz, S. Taxol resistance in murine J774 2 cells is associated with altered expression of specific β-tubulin isotypes Proc Am. Assoc. Cancer Res., 36: 318, 1995
44. Ranganathan, S., Chapman, A., Schultz, M., Bates, J., Hudes, G., and Tew, K Alterations in tubulin expression in estramustine resistant ovarian carcinoma cell lines. Proc Am. Assoc Cancer Res., 36: 454, 1995
45. Sackett, D. Structure and function in the tubulin dimer and the role of the acidic carboxyl terminus. Subcell Biochem., 24: 255-302, 1995.
46. Barde, Y Neurotrophins: a family supporting the survival of neurons. Prog Clin Biol Res., 390: 45-56, 1994
47. Harmenberg, J., Hoglund, M., and Hellstrom-Lindberg, E. G- and GM-CSF in oncology and oncological hematology. Eur J Haematol., 52: 1-28, 1994.
48. Cheung, N-K. V., and Heller, G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma J Clin. Oncol., 9: 1050-1058, 1991.
49. Harrison, D. Molecular mechanisms of drug resistance in tumors. J. Pathol., 175 7-12, 1995